# Effects of an Antioxidant Supplement on Blood Vessel Health

> **NCT06424756** · PHASE2 · RECRUITING · sponsor: **University of Georgia** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** MitoQ
- **DIETARY_SUPPLEMENT:** Placebo
- **DRUG:** MitoTempo
- **DRUG:** Tempol
- **DRUG:** L-NAME
- **DRUG:** SNP - Sodium Nitroprusside

## Key facts

- **NCT ID:** NCT06424756
- **Lead sponsor:** University of Georgia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2030-03-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06424756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06424756, "Effects of an Antioxidant Supplement on Blood Vessel Health". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06424756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*